Home Tags SH Profil Institut fur Stoffwechselforschung GmbH

SH Profil Institut fur Stoffwechselforschung GmbH Related Content

MDR clinical trials, clinical investigation

What does the European Medical Devices Regulation 2017/745 (MDR) say about clinical trials?

Professor Dr Freimut Schliess, Director of Science & Innovation at the Profil Institut für Stoffwechselforschung GmbH, explores how the MDR will impact clinical trials.
Profil Institut fur Stoffwechselforschung GmbH

Profil – leading the way in diabetes and obesity research

As a full-service CRO for early clinical trials in diabetes and obesity, Profil has brought together experts so that we can offer you unrivalled service.

On the fast-track to reimbursement: Germany unlocks business opportunities for digital health innovators

Prof. Dr. Freimut Schliess discusses digital health innovation in Germany, tackling larger public health challenges being faced.
clinical trials and clinical care, wearables

Bridging the gap between clinical trials and clinical care

Here, Tatiana Affini Dicenzo and Freimut Schliess discuss bridging the gap between clinical trials and clinical care, specifically exploring if wearables are fit for this purpose.
cardiorespiratory health

Continuous real-world monitoring of cardiorespiratory health

The importance of continuous real-world monitoring of cardiorespiratory health, including adding value to pivotal clinical trials.
digital twins

Digital twins – are they game-changers in clinical research and clinical care?

Prof Dr Freimut Schliess, Director of Science & Innovation at the Profil Institut für Stoffwechselforschung GmbH, explores if digital twins are game-changers in clinical research and clinical care.
clinical trials

A vision on remote decentralised clinical trials

Prof Dr Freimut Schliess, Director of Science & Innovation at the Profil Institut für Stoffwechselforschung GmbH, shares a vision for remote decentralised clinical trials.
innovation pathway, digital health

Think Tank highlights CROs key role in optimising innovation pathways

Prof Dr Freimut Schliess, Director of Profil GmbH, discusses how CROs can play a key role for the optimisation of innovation pathways.
RealWorld4Clinic

RealWorld4Clinic – Real-life data for clinical research & care

RealWorld4Clinic is a new European initiative bringing real-world data to pivotal clinical research and outpatient cardiology care.
artificial intelligence in healthcare

Trustworthy artificial intelligence in healthcare: It’s time to deliver

When it comes to trustworthy artificial intelligence (AI) in healthcare, Prof Dr Freimut Schliess from Profil GmbH, argues that now is the time to deliver.
iPDM

iPDM Goes Europe: The impact on diabetes and patient care

Here, the tangible impact on diabetes patients and their care is thoroughly explored via integrated personalised diabetes management (iPDM).
clinical contact research

Clinical Contract Research: Building the digital bridge between clinical research and clinical care

Prof Dr Freimut Schliess, Director, Science & Innovation at Profil GmbH, sheds light on how Clinical Contract Research Organisations are building the digital bridge connecting clinical research and clinical care.
chronic care

A life- and disease course approach to health protection and chronic care

Taking advantage of data and trustworthy collaboration is the way to go when it comes to a life- and disease course approach to health protection and chronic care, argues Prof Dr Freimut Schliess, Director of Science & Innovation at Profil GmbH.
didgital innovation

Digital innovation in diabetes: From health promotion to integrated care provision

Prof Dr Freimut Schliess, Director of Science & Innovation at the Profil Institut für Stoffwechselforschung GmbH shares his views on data-based solutions for diabetes.

Follow Open Access Government